EGFR test for the treatment of lung cancer, proportion (%) - Target level ≥ 95

Description

Proportion of lung cancer patients tested for Epidermal Growth Factor Receptor (EGFR) for active treatment of non-small cell lung cancer (excluding squamous cell cancer, stage IV). For the key figure, the National Lung Cancer Registry has set a higher target level of 95% and a lower target level of 60%.

Resources

Name Format Description Link
0 http://data.europa.eu/88u/dataset/http-api-kolada-se-v2-kpi-n70615

Tags

  • rådet-för-främjande-av-kommunala-analyser-kolada
  • region

Topics

  • GOVE
  • HEAL

Categories